|
WO03061578A2
|
|
Compositions for treatment or prevention of bioterrorism
|
|
WO0152813A1
|
|
Multi-spike release formulation for drug delivery
|
|
NZ516811A
|
|
Unit dose capsules and dry powder inhaler
|
|
AU4201900A
|
|
Methods for fine powder formation
|
|
AU7723096A
|
|
Method for fluorescent labeling of antibody
|
|
US6428771B1
|
|
Method for drug delivery to the pulmonary system
|
|
CA2159815A1
|
|
M2 receptor ligand for the treatment of neurological disorders
|
|
AU6528994A
|
|
Renin/angiotensin i diagnostic assay
|
|
US5576436A
|
|
Fluorescent ligands
|
|
WO9303382A2
|
|
Characterization of specific drug receptors with fluorescent ligands
|
|
WO9220821A1
|
|
cDNA-PHOTOFLUOR PROBE AND METHODS OF MAKING, ASSAYING AND USING SAME
|
|
US5352461A
|
|
Self assembling diketopiperazine drug delivery system
|
